Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04201132 · ClinicalTrials.gov registry record · NA

Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System

A NA study of Carotid Stenosis and Carotid Artery Diseases, sponsored by Contego Medical.

Active
Registry status
NA
Development phase
305
Enrollment target
20
Study locations

NCT04201132: Active NA study of Carotid Stenosis and Carotid Artery Diseases, sponsored by Contego Medical.

NCT04201132 is a NA study of Carotid Stenosis and Carotid Artery Diseases that is active but no longer recruiting, run by Contego Medical. The registered enrollment target is 305 participants, below the 572-participant average among 11 other Carotid Stenosis trials with a reported enrollment target (47% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04201132, a NA study of Carotid Stenosis and Carotid Artery Diseases, is active but no longer recruiting, sponsored by Contego Medical.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
305 participants
Enrollment target
20
Study locations

Study Summary

A prospective, multicenter single-arm, open label study to evaluate the safety and effectiveness of the Neuroguard IEP System for the treatment of carotid artery stenosis in subjects at elevated risk for adverse events following carotid endarterectomy (CEA).

Primary Outcome

Death, all stroke and myocardial infarction (MI)

Interventions

  • DEVICE Carotid artery stenting with Neuroguard IEP System

Study Locations (20)

Pennsylvania

  • St. Vincent Hospital - Erie
  • UPMC Hamot - Erie
  • Pinnacle Health Cardiovascular Institute - Harrisburg
  • Lankenau Institute - Wynnewood

New York

  • University at Buffalo Neurosurgery - Buffalo
  • Mt. Sinai - New York
  • Stony Brook University Medical Center - Stony Brook

Florida

  • Manatee Memorial Hospital - Bradenton
  • Lyerly Baptist Neurosurgery - Jacksonville

Alabama

  • Huntsville Hospital - Huntsville

California

  • St. Helena Hospital - St. Helena

District of Columbia

  • MedStar Washington Hospital Center - Washington D.C.

Iowa

  • University of Iowa Hospital and Clinics - Iowa City

Kentucky

  • University of Lexington - Lexington

Trial Details

FieldValue
Enrollment Target 305 participants
Start Date 2020-06-12
Est. Completion 2025-12
Phase NA
Contego Medical

2 total trials

What the registry record for NCT04201132 still lists

NCT04201132 is an interventional study that assigns participants to a tested intervention. The registered 305 participants enrollment target is mid-sized for trials with a published cap, below the 572-participant average among 11 other Carotid Stenosis trials with a reported enrollment target (47% lower).

The record links to 3 conditions, with Carotid Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Carotid artery stenting with Neuroguard IEP System is the first listed.

NCT04201132 names 20 study sites across 14 states, led by Pennsylvania, New York, Florida.

Frequently Asked Questions

What is clinical trial NCT04201132 about?

NCT04201132 is a clinical study titled "Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System". A prospective, multicenter single-arm, open label study to evaluate the safety and effectiveness of the Neuroguard IEP System for the treatment of carotid artery stenosis in subjects at elevated risk for adverse events following carotid endarterectomy (CEA).

What is the current status of trial NCT04201132?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 305 participants. The study started on 2020-06-12. Estimated completion is 2025-12.

What conditions does trial NCT04201132 study?

This clinical trial studies the following conditions: Carotid Stenosis, Carotid Artery Diseases, Carotid Artery Stenosis.

What interventions are being tested in trial NCT04201132?

The interventions under investigation include: Carotid artery stenting with Neuroguard IEP System (DEVICE).

Who is sponsoring clinical trial NCT04201132?

This trial is sponsored by Contego Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04201132 being conducted?

This trial has 20 study locations across Alabama, California, District of Columbia, Florida, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Carotid Stenosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04201132's enrollment target sits among peer trials

305 4th of 11 higher than 8 of 11 other Carotid Stenosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Carotid Stenosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04107181 · 305 participants · NA

    Pilot Study for Speculum Free Cervical Cancer Screening

  • NCT05399056 · 305 participants · NA

    Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling

  • NCT05078970 · 306 participants · NA

    Advancing Suicide Intervention Strategies for Teens During High Risk Periods

  • NCT05843695 · 306 participants · NA

    Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04201132, the US trial registry maintained by the National Library of Medicine. NCT04201132 (mid enrollment · wide site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.